China’s 6 Dimensions Capital, which was formed through the merger of WuXi Healthcare Ventures and Frontline BioVentures, has raised approximately $844 million for its debut healthcare fund.
The vehicle comprises two pools of capital: a US dollar-denominated tranche that closed at $533 million and renminbi tranche of RMB2.06 billion ($311 million). The targets were $450 million and RMB1.5...
Novo Tellus Capital Partners, an investor in industrial technology assets across the Indo-Pacific region, has reached a first close of approximately USD 375m on its third fund – matching the overall target for the vehicle.
Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.
Trifecta Capital has closed its third India venture debt fund with about INR 17.8bn (USD 214) in commitments. The initial target was INR 10bn with a greenshoe option of INR 5bn.
Asia-focused industrial technology investor ShawKwei & Partners has announced its third investment in a US-based company in three weeks, with a USD 34.3m commitment to battery manufacturer Group14 Technologies.